Page last updated: 2024-08-17

edetic acid and Atherosclerosis

edetic acid has been researched along with Atherosclerosis in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19905 (35.71)18.7374
1990's0 (0.00)18.2507
2000's1 (7.14)29.6817
2010's7 (50.00)24.3611
2020's1 (7.14)2.80

Authors

AuthorsStudies
Song, T; Zhang, D1
Jahangir, A; Mookadam, F; Murarka, S; Sultan, S; Tajik, AJ1
Aude, YW; Diaz, D; Fonseca, V; Lamas, GA1
Calderon Moreno, R; Diaz, D; Escolar, E; Fonseca, V; Lamas, GA; Nathan, DM; Navas-Acien, A; Newman, J; Schmedtje, JF1
Boineau, R; Drisko, J; Goertz, C; Lamas, GA; Lee, KL; Lewis, EF; Lindblad, L; Mark, DB; Nahin, RL; Rozema, T1
Altekin, RE; Gülcan, AR; Karakaş, MS1
Avila, MD; Escolar, E; Lamas, GA1
Issa, OM; Lamas, GA1
BOYLE, AJ; CLARKE, NE; GOODWIN, J; JASPER, JJ; KOSAI, M; MCCANN, D; MCCORMICK, H; MOSHER, RE1
CLARKE, NE1
BOYLE, AJ; KOEN, A; MCCANN, DS; ZDYBEK, G1
ARONOV, DM1
BOYLE, AJ; LACSON, T; MCCANN, DS1
Simon, HB1

Reviews

5 review(s) available for edetic acid and Atherosclerosis

ArticleYear
Chelation therapy in cardiovascular disease: an update.
    Expert review of clinical pharmacology, 2017, Volume: 10, Issue:8

    Topics: Animals; Atherosclerosis; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Coronary Artery Disease; Edetic Acid; Humans; Myocardial Infarction; Off-Label Use; Randomized Controlled Trials as Topic; Treatment Outcome

2017
Chelation therapy to prevent diabetes-associated cardiovascular events.
    Current opinion in endocrinology, diabetes, and obesity, 2018, Volume: 25, Issue:4

    Topics: Atherosclerosis; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Diabetes Mellitus; Diabetic Cardiomyopathies; Edetic Acid; Glycation End Products, Advanced; Humans; Metals; Myocardial Infarction; National Institutes of Health (U.S.); Oxidation-Reduction; Randomized Controlled Trials as Topic; United States

2018
Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    The Journal of clinical endocrinology and metabolism, 2019, 07-01, Volume: 104, Issue:7

    Topics: Antioxidants; Arsenic; Ascorbic Acid; Atherosclerosis; Cadmium; Calcium Chelating Agents; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Copper; Diabetes Complications; Diabetes Mellitus; Edetic Acid; Glycation End Products, Advanced; Hospitalization; Humans; Iron; Lead; Lipid Metabolism; Mercury; Myocardial Infarction; Myocardial Revascularization; Oxidative Stress; Randomized Controlled Trials as Topic; Stroke

2019
Chelation therapy after the trial to assess chelation therapy: results of a unique trial.
    Current opinion in cardiology, 2014, Volume: 29, Issue:5

    Topics: Atherosclerosis; Chelation Therapy; Diabetes Complications; Edetic Acid; Humans; Randomized Controlled Trials as Topic

2014
Edetate Disodium-Based Treatment for Secondary Prevention in Post-Myocardial Infarction Patients.
    Current cardiology reports, 2016, Volume: 18, Issue:2

    Topics: Atherosclerosis; Calcium Chelating Agents; Chelation Therapy; Dose-Response Relationship, Drug; Double-Blind Method; Edetic Acid; Heavy Metal Poisoning; Humans; Metals, Heavy; Myocardial Infarction; Poisoning; Risk Factors; Secondary Prevention; Survivors; Treatment Outcome

2016

Trials

1 trial(s) available for edetic acid and Atherosclerosis

ArticleYear
Effect of disodium EDTA chelation regimen on cardiovascular events in patients with previous myocardial infarction: the TACT randomized trial.
    JAMA, 2013, Mar-27, Volume: 309, Issue:12

    Topics: Aged; Angina Pectoris; Atherosclerosis; Chelating Agents; Double-Blind Method; Edetic Acid; Female; Hospitalization; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Percutaneous Coronary Intervention; Recurrence; Risk; Stroke; Treatment Outcome

2013

Other Studies

8 other study(ies) available for edetic acid and Atherosclerosis

ArticleYear
Evaluation on curative effects of ethylene diamine tetra-acetic acid chelation therapy in treating with atherosclerotic cardiovascular disease: A protocol for systematic review and meta-analysis.
    Medicine, 2020, Dec-24, Volume: 99, Issue:52

    Topics: Atherosclerosis; Calcium; Chelation Therapy; Edetic Acid; Humans; Meta-Analysis as Topic; Research Design; Systematic Reviews as Topic

2020
[Authors reply].
    Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2014, Volume: 42, Issue:3

    Topics: Angina Pectoris; Atherosclerosis; Blood Specimen Collection; Cardiovascular Agents; Coronary Angiography; Edetic Acid; Humans; Mean Platelet Volume; Metabolic Syndrome; Thromboxane A2

2014
Studies in human and induced atherosclerosis employing ethylenediaminetetraacetic acid.
    Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften, 1957, Volume: 13, Issue:1-4

    Topics: Arteriosclerosis; Atherosclerosis; Coronary Disease; Edetic Acid; Heart Diseases; Humans

1957
Atherosclerosis, occlusive vascular disease and EDTA.
    The American journal of cardiology, 1960, Volume: 6

    Topics: Atherosclerosis; Cardiovascular Diseases; Edetic Acid; Humans; Peripheral Vascular Diseases; Vascular Diseases

1960
Effect of chelation on phosphorus metbolism in experimental atherosclerosis.
    Circulation research, 1962, Volume: 11

    Topics: Arteriosclerosis; Atherosclerosis; Chelating Agents; Edetic Acid; Phosphorus

1962
[1ST EXPERIENCE WITH THE TREATMENT OF ATHEROSCLEROSIS PATIENTS WITH CALCINOSIS OF THE ARTERIES WITH TRILON B (DISODIUM SALT OF EDTA)].
    Klinicheskaia meditsina, 1963, Volume: 41

    Topics: Arteries; Arteriosclerosis; Atherosclerosis; Calcinosis; Calcium Metabolism Disorders; Edetic Acid; Humans

1963
THE EFFECT OF PARENTERAL CITRATE ON AORTIC PHOSPHATE IN INDUCED ATHEROSCLEROSIS.
    Life sciences (1962), 1964, Volume: 3

    Topics: Aorta; Arteriosclerosis; Atherosclerosis; Calcium; Cholesterol; Citrates; Citric Acid; Edetic Acid; Freeze Drying; Pharmacology; Phosphates; Phospholipids; Rabbits; Research; Toxicology

1964
On call. I know you have expressed reservations about alternative therapy from time to time. I realize that it's a tricky issue for doctors, but I find the idea appealing. In particular, I'd like your opinion about chelation therapy. I'm a 68-year-old dia
    Harvard men's health watch, 2005, Volume: 10, Issue:5

    Topics: Aged; Atherosclerosis; Calcium; Chelating Agents; Chelation Therapy; Edetic Acid; Humans; Male

2005